CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
02171.HK stock price ended at $14 on Perşembe, after dropping 0.64%
On the latest trading day Feb 12, 2026, the stock price of 02171.HK fell by 0.64%, dropping from $14.09 to $14.00. During the session, the stock saw a volatility of 3.26%, with prices oscillating between a daily low of $13.82 and a high of $14.27. On the latest trading day, the trading volume for 02171.HK rose by 474.0K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 964.0K shares were traded, with a market value of approximately $7.6B.
02171.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 0
Nötr Sinyaller 2
Satış Sinyalleri 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
02171.HK, şu anda 0 alım sinyali ve 5 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -0.64% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Strong Sell görünüm işaret etmektedir.
02171.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 02171.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.